{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:59:56Z","timestamp":1781528396102,"version":"3.54.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-genitourinary-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.clgc.2025.102306","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T08:50:36Z","timestamp":1737622236000},"page":"102306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nonintravesical Interventions for Preventing Intravesical Recurrence in Patients With Nonmuscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3135-8262","authenticated-orcid":false,"given":"Ichiro","family":"Tsuboi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Kardoust Parizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Mancon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Fazekas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Miszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cadenar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Laukhtina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Rajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsushi","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Bekku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Chlosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoo","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2025.102306_bib0001","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102306_bib0002","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(09)60491-8","article-title":"Bladder cancer","volume":"374","author":"Kaufman","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.clgc.2025.102306_bib0003","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102306_bib0004","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.urolonc.2023.04.003","article-title":"The efficacy and safety outcomes of lower dose BCG compared to intravesical chemotherapy in non-muscle-invasive bladder cancer: a network meta-analysis","volume":"41","author":"Kawada","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2025.102306_bib0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102306_bib0006","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2217\/imt-2022-0309","article-title":"Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysis","volume":"15","author":"Kawada","year":"2023","journal-title":"Immunother"},{"key":"10.1016\/j.clgc.2025.102306_bib0007","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/MOU.0000000000001065","article-title":"Sequential intravesical gemcitabine and docetaxel therapy in patients with nonmuscle invasive bladder cancer: a systematic review and meta-analysis","volume":"33","author":"Kawada","year":"2023","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.clgc.2025.102306_bib0008","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ajcnut.2023.04.006","article-title":"Associations of dietary isothiocyanate exposure from cruciferous vegetable consumption with recurrence and progression of non-muscle-invasive bladder cancer: findings from the be-well study","volume":"117","author":"Wang","year":"2023","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clgc.2025.102306_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.37494","article-title":"Selenium and vitamin E for prevention of non-muscle-invasive bladder cancer recurrence and progression: a randomized clinical trial","volume":"6","author":"Bryan","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clgc.2025.102306_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.11622\/smedj.2020121","article-title":"Beyond diabetes mellitus: role of metformin in non-muscle-invasive bladder cancer","volume":"63","author":"Wang","year":"2022","journal-title":"Singapore Med J"},{"key":"10.1016\/j.clgc.2025.102306_bib0011","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.eururo.2018.09.020","article-title":"BOXIT-A randomised phase III placebo-controlled trial evaluating the addition of Celecoxib to standard treatment of transitional cell carcinoma of the bladder (CRUK\/07\/004)","volume":"75","author":"Kelly","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102306_bib0012","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/ijc.31214","article-title":"Dietary patterns and risk of recurrence and progression in non-muscle-invasive bladder cancer","volume":"142","author":"Westhoff","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clgc.2025.102306_bib0013","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/ajcn\/nqx019","article-title":"Is folic acid safe for non-muscle-invasive bladder cancer patients? An evidence-based cohort study","volume":"107","author":"Tu","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clgc.2025.102306_bib0014","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10552-018-1029-9","article-title":"Fruit and vegetable intake and the risk of recurrence in patients with non-muscle invasive bladder cancer: a prospective cohort study","volume":"29","author":"Jochems","year":"2018","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clgc.2025.102306_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejca.2016.09.021","article-title":"Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer trial","volume":"69","author":"Goossens","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2025.102306_bib0016","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1158\/1940-6207.CAPR-11-0036","article-title":"A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer","volume":"4","author":"Sabichi","year":"2011","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.clgc.2025.102306_bib0017","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.juro.2010.06.147","article-title":"Bacillus Calmette-Gu\u00e9rin with or without interferon \u03b1-2b and megadose versus recommended daily allowance vitamins during induction and maintenance intravesical treatment of nonmuscle invasive bladder cancer","volume":"184","author":"Nepple","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2025.102306_bib0018","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1158\/1078-0432.CCR-07-0733","article-title":"Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer","volume":"14","author":"Sabichi","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2025.102306_bib0019","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.juro.2007.09.031","article-title":"Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer","volume":"179","author":"Naito","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2025.102306_bib0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0022-5347(05)64834-3","article-title":"Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial","volume":"168","author":"Goebell","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2025.102306_bib0021","first-page":"1071","article-title":"Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point","volume":"9","author":"Decensi","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clgc.2025.102306_bib0022","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000475068","article-title":"Adjuvant treatment with a vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors. Final analysis of a prospective, randomized multicenter trial in Switzerland","volume":"28","author":"Studer","year":"1995","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102306_bib0023","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000475139","volume":"27","author":"Newling","year":"1995","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102306_bib0024","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000475138","article-title":"Preventive effect of a lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group","volume":"27","author":"Aso","year":"1995","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102306_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-5347(17)34863-2","article-title":"Megadose vitamins in bladder cancer: a double-blind clinical trial","volume":"151","author":"Lamm","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2025.102306_bib0026","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6947-7-16","article-title":"Utilization of the PICO framework to improve searching PubMed for clinical questions","volume":"7","author":"Schardt","year":"2007","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.clgc.2025.102306_bib0027","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.clgc.2025.102306_bib0028","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.clgc.2025.102306_bib0029","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.eururo.2018.12.014","article-title":"Guidelines for reporting of statistics for clinical research in urology","volume":"75","author":"Assel","year":"2019","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102306_bib0030","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s12602-023-10116-z","article-title":"The role of biotics as a therapeutic strategy for oral mucositis - a systematic review","volume":"16","author":"Frey-Furtado","year":"2024","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10.1016\/j.clgc.2025.102306_bib0031","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.clnu.2022.10.015","article-title":"Probiotics and synbiotics in chronic constipation in adults: a systematic review and meta-analysis of randomized controlled trials","volume":"41","author":"van der Schoot","year":"2022","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clgc.2025.102306_bib0032","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/pai.13305","article-title":"Comparative effectiveness of probiotic strains for the treatment of pediatric atopic dermatitis: a systematic review and network meta-analysis","volume":"32","author":"Tan-Lim","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.clgc.2025.102306_bib0033","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3582989","article-title":"Probiotics as a new regulator for bone health: a systematic review and meta-analysis","volume":"2021","author":"Malmir","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.clgc.2025.102306_bib0034","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/1751-2980.12839","article-title":"Which probiotic has the best effect on preventing Clostridium difficile-associated diarrhea? A systematic review and network meta-analysis","volume":"21","author":"Ma","year":"2020","journal-title":"J Dig Dis"},{"key":"10.1016\/j.clgc.2025.102306_bib0035","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/ijo.2017.161","article-title":"Effect of Lactobacillus on body weight and body fat in overweight subjects: a systematic review of randomized controlled clinical trials","volume":"41","author":"Crovesy","year":"2017","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.clgc.2025.102306_bib0036","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ppul.23643","article-title":"Network meta-analysis of probiotics to prevent respiratory infections in children and adolescents","volume":"52","author":"Amaral","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clgc.2025.102306_bib0037","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/cas.15666","article-title":"Probiotics enhances anti-tumor immune response induced by gemcitabine plus cisplatin chemotherapy for urothelial cancer","volume":"114","author":"Miyake","year":"2023","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clgc.2025.102306_bib0038","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3835(95)03786-V","article-title":"Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC","volume":"93","author":"Mirvish","year":"1995","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clgc.2025.102306_bib0039","article-title":"Urinary levels of N-nitroso compounds in relation to risk of gastric cancer: findings from the shanghai cohort study","volume":"10","author":"Xu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clgc.2025.102306_bib0040","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1016\/j.ejca.2012.05.026","article-title":"Fruit and vegetable consumption and risk of aggressive and non-aggressive urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition","volume":"48","author":"Ros","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2025.102306_bib0041","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1002\/ijc.25592","article-title":"Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC)","volume":"128","author":"Ros","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clgc.2025.102306_bib0042","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.urology.2009.07.1260","article-title":"Evidence-based principles of bladder cancer and diet","volume":"75","author":"Silberstein","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2025.102306_bib0043","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/jnci\/djj494","article-title":"Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study","volume":"98","author":"Chlebowski","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clgc.2025.102306_bib0044","doi-asserted-by":"crossref","first-page":"g4490","DOI":"10.1136\/bmj.g4490","article-title":"Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies","volume":"349","author":"Wang","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.clgc.2025.102306_bib0045","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1096\/fj.01-0299fje","article-title":"COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib","volume":"15","author":"Gr\u00f6sch","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.clgc.2025.102306_bib0046","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0090-4295(02)01909-X","article-title":"Association of cyclooxygenase-2 expression with prognosis of stage T1 grade 3 bladder cancer","volume":"60","author":"Kim","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2025.102306_bib0047","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJMoa061355","article-title":"Celecoxib for the prevention of sporadic colorectal adenomas","volume":"355","author":"Bertagnolli","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clgc.2025.102306_bib0048","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00204-010-0595-8","article-title":"Selenium: a double-edged sword for defense and offence in cancer","volume":"84","author":"Brozmanov\u00e1","year":"2010","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.clgc.2025.102306_bib0049","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2174\/138955708785740625","article-title":"Selenium compounds and apoptotic modulation: a new perspective in cancer therapy","volume":"8","author":"Sanmart\u00edn","year":"2008","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.clgc.2025.102306_bib0050","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S1470-2045(06)70862-2","article-title":"Use of selenium in chemoprevention of bladder cancer","volume":"7","author":"Brinkman","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clgc.2025.102306_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S1020-49892005000600001","article-title":"Cancer mortality in Latin America: implications for prevention","volume":"18","author":"Bosetti","year":"2005","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.clgc.2025.102306_bib0052","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1442-2042.2006.01526.x","article-title":"Selenium is inversely associated with bladder cancer risk: a report from the Belgian case-control study on bladder cancer","volume":"13","author":"Kellen","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.clgc.2025.102306_bib0053","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.2011.1437","article-title":"Vitamin E and the risk of prostate cancer: the selenium and Vitamin E cancer prevention trial (SELECT)","volume":"306","author":"Klein","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.clgc.2025.102306_bib0054","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.autrev.2009.02.011","article-title":"Vitamin D: the alternative hypothesis","volume":"8","author":"Albert","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clgc.2025.102306_bib0055","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.nut.2015.10.023","article-title":"Comparative efficacy of vitamin D status in reducing the risk of bladder cancer: a systematic review and network meta-analysis","volume":"32","author":"Zhao","year":"2016","journal-title":"Nutrition"},{"key":"10.1016\/j.clgc.2025.102306_bib0056","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin\u2013mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.clgc.2025.102306_bib0057","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.ejca.2008.02.043","article-title":"Blocking on the CXCR4\/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells","volume":"44","author":"Hashimoto","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2025.102306_bib0058","doi-asserted-by":"crossref","first-page":"24603","DOI":"10.3390\/ijms141224603","article-title":"The antidiabetic drug metformin inhibits the proliferation of bladder cancer cells in vitro and in vivo","volume":"14","author":"Zhang","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.clgc.2025.102306_bib0059","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/jnci\/djae021","article-title":"Association of metformin use and cancer incidence: a systematic review and meta-analysis","volume":"116","author":"O\u2019Connor","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clgc.2025.102306_bib0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/ijpvm.ijpvm_62_21","article-title":"The relationship between metformin consumption and cancer risk: an updated umbrella review of systematic reviews and meta-analyses","volume":"14","author":"Najafi","year":"2023","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.clgc.2025.102306_bib0061","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3835(96)04401-1","article-title":"Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes","volume":"109","author":"Rib\u00e9reau-Gayon","year":"1996","journal-title":"Cancer Lett"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T12:44:05Z","timestamp":1741697045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325000084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1558767325000084"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102306","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonintravesical Interventions for Preventing Intravesical Recurrence in Patients With Nonmuscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102306"}}